Drugmakers sue Kansas over 340B law

A Kansas law compels drugmakers to extend 340B program discounts to contract pharmacies. In early July, AstraZeneca and AbbVie filed lawsuits against the legislation, according to court documents obtained by Becker’s. 

Advertisement

AbbVie said contract pharmacies have used the law, Senate Bill 28, to “acquire manufacturers’ drugs at the federally discounted price, sell them to patients (including indigent patients) at full price, and pocket the difference.”

The two pharmaceutical companies challenged the constitutionality of the law and are seeking to nullify it.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.